The Future Is Now: A Closer Look at Implantable Anti-VEGF Technology

The Future Is Now: A Closer Look at Implantable Anti-VEGF Technology

The Future Is Now: A Closer Look at Implantable Anti-VEGF Technology

Our experts share their insights on integrating the port delivery system into medical and surgical practices to optimize the treatment of nAMD.

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Whether you’re a medical or surgical retina specialist, the port delivery system (PDS) is a practice-changing treatment modality. How can you smoothly incorporate continuous anti-VEGF delivery technology into your clinical practice? Join Dr. SriniVas Sadda and Dr. John Kitchens as they discuss how the PDS fits into our treatment arsenal.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    John W. Kitchens, MD

    Vitreoretinal Surgeon
    Retina Associates of Kentucky
    Lexington, KY 

    Commercial Interest Speakers Bureau: Alcon, Bayer, Genentech, Kodiak Bioscience, Regeneron
    Consulting Fees: Alcon, Alimera, Allergan, Apellis, Bayer, Biogen, Genentech, Kodiak Bioscience, Notal Vision, Optos, Oculus, Outlook, Regeneron, Roche, Zeiss
    Ownership Interest: Kodiak Bioscience, Outlook

    SriniVas R. Sadda, MD

    Director, Artificial Intelligence & Imaging Research
    Doheny Eye Institute
    Professor of Ophthalmology
    UCLA, David Geffen School of Medicine
    Pasadena, CA

    Consulting Fees: Allergan, Amgen, Apellis, Biogen, Boehringer Ingelheim, CenterVue, Heidelberg Engineering, Iveric Bio, Jannsen, Pfizer, Novartis, Optos, Oxurion, Roche/Genentech
    Contracted Research: Carl Zeiss Meditec, Optos
    Research Instruments: Carl Zeiss Meditec, CenterVue, Heidelberg Engineering, Nidek, Optos, Topcon

    Reviewers/Content Planners/Authors:

    • Stephen Chavez has nothing to disclose.
    • Cindy Davidson has nothing to disclose.
    • Ann Early has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Stephanie Wenick, MPhil, has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Discuss the relationship between fluctuations in retinal thickening and vision outcomes
    • Identify patients who would benefit from extended delivery of anti-VEGF therapy
  • Target Audience

    This activity is designed to meet the educational needs of retina specialists, ophthalmologists, and optometrists.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Global Learning Collaborative is accredited by COPE to provide continuing education to optometrists.

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the  credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 0.25 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    This course is COPE approved for 0.25 hours of CE credit. The course number is 80872-TD and the activity number is 124741. Check with your local state licensing board to see if this counts toward your CE requirement for relicensure.

  • Provider(s)/Educational Partner(s)

    Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. 

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research.  

  • Commercial Support

    This activity is supported by an independent educational grant from Genentech, a member of the Roche Group.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments


We’re glad to see you’re enjoying Eye Health Academy…
but how about a more personalized experience?

Register for free